Report cover image

Middle East and Asia Injectable Drugs Market, by Product Type (Pre-filled Syringes, Auto-injectors, Pre-filled Pens, Pre-mixed IV Bags, and Others), by Drug Class (Anesthesia, Antibiotics, Antidotes, Antiemetic, Anti-infective, Anti-thrombolytic, Muscle R

Publisher Coherent Market Insights
Published Jan 31, 2022
Length 90 Pages
SKU # CMI16970942

Description

Middle East and Asia Injectable Drugs Market, by Product Type (Pre-filled Syringes, Auto-injectors, Pre-filled Pens, Pre-mixed IV Bags, and Others), by Drug Class (Anesthesia, Antibiotics, Antidotes, Antiemetic, Anti-infective, Anti-thrombolytic, Muscle Relaxant, Non Opioids, Opioids, Sedatives, and Others), by Route of Administration (Intramuscular (IM), Intravenous (IV), Subcutaneous (SC), and Others (Epidural and Intrathecal)), and by End Users (Hospitals, Clinics, and Ambulatory Surgery Centers) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

Injectable drug delivery is considered as the most effective route of administration for the effective delivery of drugs to the targeted site. Injectable delivery facilitates rapid absorption of drug from various route of administration such as subcutaneous, intravenous, and intramuscular. Injectable delivery increases the bioavailability of the drug at the systemic circulation. The increasing prevalence of chronic diseases, technological advancements, demand for individual therapy, awareness regarding drug metabolism among the population, and requirement of controlled drug release are the major factors driving the growth of the Middle East and Asia injectable drugs market.

Middle East and Asia injectable drugs market is estimated to be valued at US$ 4,15,000 Mn in 2021 and is expected to increase to US$ 7,23,164 Mn by 2028, witnessing a CAGR of 8.2% during the forecast period.

Market Dynamics

Increase in technology advancement, increasing government initiatives in healthcare sector of Middle East, innovations and ongoing R&Ds on injectable drug delivery systems and increasing adoption of inorganic growth strategies such as mergers, acquisitions, partnerships, and collaborations by key players operating in the market are the major factors that are expected to drive the growth of the Middle East and Asia injectable drugs market.

As per the article Bevan Brittan, 2020, The Middle East is seeing a boom in healthcare sector. Aging populations, lengthening life expectations, and different lifestyle are the factors driving the market growth. The opportunities are leading to new models of care and out of hospital facilities because of the focus on prevention and not just simple treatment. Encompassing the primary, community and secondary care, the Saudi Arabia has embarked to build a new healthcare system.

Key features of the study:
  • This report provides in-depth analysis of the Middle East and Asia injectable drugs market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the Middle East and Asia injectable drugs market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Kalbe Farma, Takeda pharmaceuticals Co. Ltd., Livzon Pharmaceutical Group, Inc., Sun Pharmaceutical Industries, Ltd., Pfizer, Inc., Sanofi, Novartis, Tabuk, Novo Nordisk, GlaxoSmithKline plc, AstraZeneca, and Gerresheimer AG
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The Middle East and Asia injectable drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Middle East and Asia injectable drugs market
Detailed Segmentation:
  • Middle East and Asia Injectable Drugs Market, By Product Type:
  • Pre-filled Syringes
  • Vaccines
  • Blood Stimulants
  • Biologics
  • Others
  • Auto-injectors
  • Pre-filled Pens
  • Pre-mixed IV Bags
  • Sedative Products (Sedation)
  • Anesthesia Products (Anesthesia)
  • Pain Management Products (Post-operative analgesic pain management)
  • Chemotherapy Products (Chemotherapy)
  • Antibacterial Products (Infectious diseases)
  • Electrolyte and Nutrition Products (Electrolyte and Nutrition)
  • Others
  • Middle East and Asia Injectable Drugs Market, By Route of Administration:
  • Intramuscular (IM)
  • Intravenous (IV)
  • Subcutaneous (SC)
  • Others (Epidural and Intrathecal)
  • Middle East and Asia Injectable Drugs Market, By Drug Class:
  • Anesthesia
  • Antibiotics
  • Antidotes
  • Antiemetic
  • Anti-infective
  • Anti-thrombolytic
  • Muscle Relaxant
  • Non Opioids
  • Opioids
  • Sedatives
  • Others
  • Middle East and Asia Injectable Drugs Market, By End Users:
  • Hospitals
  • Clinics
  • Ambulatory Surgery Centers
  • Company Profiles
  • Kalbe Farma*
  • Company highlights
  • Product Portfolio
  • Key Highlights
  • Financial performance
  • Strategies
  • Takeda pharmaceuticals Co. Ltd.
  • Livzon Pharmaceutical Group, Inc.
  • Sun Pharmaceutical Industries, Ltd.
  • Pfizer, Inc.
  • Sanofi
  • Novartis
  • Tabuk
  • Novo Nordisk
  • GlaxoSmithKline plc
  • AstraZeneca
  • Gerresheimer AG
“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

90 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Product Type
Market Snippet, By Application
Market Snippet, By End User
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
PEST Analysis
Epidemiology
Alternative To Wound Care Biologics
Regulatory Scenario
Reimbursement Scenario
Collaborations and Agreements
4. Colombia Wound Care Biologics Market – Impact of Coronavirus (Covid-19) Pandemic
Economic Impact
Impact on Clinical Trials and Drug Development
Government Initiatives
5. Colombia Wound Care Biologics Market, By Product Type, 2021 – 2028, (US$ Mn.)
Introduction
Market Share Analysis, 2021 and 2028 (%)
Y-o-Y Growth Analysis, 2018 – 2028
Segment Trends
Biologic Skin Substitutes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn.)
Enzyme Based Formulations
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn.)
Growth Factors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn.)
6. Colombia Wound Care Biologics Market, By Application, 2021 – 2028, (US$ Mn.)
Introduction
Market Share Analysis, 2021 and 2028 (%)
Y-o-Y Growth Analysis, 2018 – 2028
Segment Trends
Chronic Wounds
• Diabetic Foot Ulcer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn.)
• Venous Leg Ulcer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn.)
• Pressure Ulcer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn.)
Acute Wounds
• Surgical Wounds
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn.)
• Burns
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn.)
7. Colombia Wound Care Biologics Market, By End User, 2021 – 2028, (US$ Mn.)
Introduction
Market Share Analysis, 2021 and 2028 (%)
Y-o-Y Growth Analysis, 2018 – 2028
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn.)
Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn.)
Ambulatory Surgical Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn.)
Home Care Settings
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn.)
8. Competitive Landscape
Heat Map Analysis
Market Share Analysis
Smith & Nephew, Plc*
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Organogenesis, Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Integra Life Sciences Corporation
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
MiMedx Group, Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Skye Biologics, Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Amino Technology LLC
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Osiris Therapeutics, Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Alphatec Holdings, Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Mallinckrodt Plc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Amniox Medical, Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Acelity L.P. Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
ConvaTec Group Plc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Generex Biotechnology Corporation
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Olaregen Therapeutix Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Analyst Views
9. Section
References
Research Methodology
About Us and Sales Contact
*Browse 10 market data tables and 20 figures on "Wound Care Biologics Market” - Colombia forecast to 2028

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us